Updates in anti-HER2 combination therapy
Burstein, H.
Clinical Advances in Hematology and Oncology H&o 6(12): 873-874
2008
ISSN/ISBN: 1543-0790 PMID: 19209136 Document Number: 621856
Document emailed within 1 workday
Related Documents
Materson, B.J.; Reda, D.J.; Cushman, W.C.; Henderson, W.G. 1995: Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents Journal of human hypertension 9(10): 791-796Fiedelman, W.; Martens, J. 1974: "Combination" anti-asthmatic therapy: recent developments Current Therapeutic Research 16(3): 224-231
Kumar, B.; Singh, S.; Skvortsova, I.; Kumar, V. 2017: Promising Targets in Anti-cancer Drug Development: Recent Updates Current Medicinal Chemistry 24(42): 4729-4752
Takada, N. 1990: Effects of combination therapy with hyperthermia and immuno-targeting chemotherapy using anti-AFP antigen on hepatocellular carcinoma Hokkaido Journal of Medical Science 65(4): 384-391
Brockmeyer, N.H.; Potthoff, A.; Kasper, A.; Nabring, C.; Jöckel, K.-H.; Siffert, W. 2005: GNB3 C825T polymorphism and response to anti-retroviral combination therapy in HIV-1-infected patients--a pilot study European Journal of Medical Research 10(11): 489-494
Kitaura, K.; Asano, K. 2005: A case of anti-GBM-antibody positive rapidly progressive glomerulonephritis who was weaned from hemodialysis after combination therapy with steroid and plasmapheresis Nihon Jinzo Gakkai Shi 47(8): 887-892
Hioki, M.; Kagawa, S.; Fujiwara, T.; Sakai, R.; Kojima, T.; Watanabe, Y.; Hashimoto, Y.; Uno, F.; Tanaka, N.; Fujiwara, T. 2008: Combination of oncolytic adenovirotherapy and Bax gene therapy in human cancer xenografted models. Potential merits and hurdles for combination therapy International Journal of Cancer 122(11): 2628-2633
Antoni, C.; Kalden, J.R. 1999: Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 17(6 Suppl 18: S73-S77
Akamatsu, H.; Tsukuura, T.; Matsunaga, H.; Suzuki, A. 1993: Study of combination therapy for thymoma: a case of stage IV which presented as total spinal block caused by epidural metastasis and which preoperative combination therapy was effective for minimizing the tumor Kyobu Geka. Japanese Journal of Thoracic Surgery 46(13): 1156-1160
Kanra, T.; Pirnar, A. 1977: Isoimmunization and hemolytic transfusion reaction due to anti-c and anti-Jk combination Turkish Journal of Pediatrics 19(1-2): 31-38
Ressel, G. 2001: CDC updates interim guidelines for anthrax exposure management and antimicrobial therapy American Family Physician 64(11): 1901-2 1904
Beatty, G.; Hunt, P.; Smith, A.; Hoh, R.; Huang, W.; Martin, J.; Deeks, S.G. 2006: A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide Antiviral Therapy 11(3): 315-319
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Mehta, S.R. 2002: Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines Journal of Invasive Cardiology 14 Suppl E: 27e-34e; Quiz 35e
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Pantazis, P.; Han, Z.; Balan, K.; Wang, Y.; Wyche, J.H. 2003: Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models Anticancer Research 23(5a): 3623-3638
Mukai, M.; Ando, K.; Koike, S.; Ishikawa, T.; Ryu, M.; Nagashima, T.; Nagao, K.; Isono, K. 1986: Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Part 1): 556-562
Kitamura, T.; Maruyama, T.; Nakamura, H.; Hayashi, K.; Shigehira, M.; Iwaki, Y.; Okamoto, T.; Ishikawa, T.; Ishinoda, Y.; Kisanuki, H. 1990: Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(8 Part 1): 1467-1471
Stanford, C.M. 2016: The Jedi Dark Side of Implant Therapy? Peri-implant Disease(s): Recent Updates on Prevalence and Etiology International Journal of Oral and Maxillofacial Implants 31(1): 17-22
Li, J.; Merl, M.Yee.; Chabot, J.; Saif, M.Wasif. 2010: Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010 JOP: Journal of the pancreas 11(4): 310-312